News

Article

Roche Canada to Invest $500 Million and Create 500 New Jobs at its Canadian Global Pharma Technical Operations Site

200 employees will be hired by the end of 2020, with 300 more planning to be hired by 2023.

Roche Canada announced on Oct. 16, 2020 that it will create 500 jobs and invest $500 million over the course of five years to establish a new Global Pharma Technical Operations site at its Canadian pharmaceutical headquarters in Mississauga, Ontario.

According to a company press release, 200 employees will be hired by the end of 2020, with 300 more planning to be hired by 2023.

“Ontario was selected for this investment based on a strong competitive business environment, exceptional talent pool, and a government committed to fostering growth in the sector,” said Ronnie Miller, president and CEO of Roche Pharmaceuticals, Canada, in the press release. “We applaud the hard work done by the Government of Ontario and the Premier’s Office to foster a business environment that can compete internationally to attract investment opportunities, and Roche’s commitment to add up to 500 specialized positions is a direct result of these positive changes.”

Source: Roche Canada

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content